Fig. 2.

Comparison of sustained virological response (SVR) rates according to baseline characteristics and on-treatment factors. The SVR rates were significantly better in chronic hepatitis C patients infected with genotype 2/3 (A), low pre-treatment viral load (B), male gender (C), age less than 40 years (D), and less advanced fibrosis on histology (E). During treatment, achievement of early virological response (EVR) (F) and adherence (a cumulative drug dose greater than 80% of the planned dose) (G) were associated with better SVR rate.